Innospec Announces New $50 Million Share Repurchase Program

12.03.25 12:21 Uhr

Werte in diesem Artikel
Aktien

90,00 EUR 1,00 EUR 1,12%

Innospec Inc. IOSP recently announced that its board has approved a new $50 million share repurchase program. The company's earlier $50 million program expired in the first quarter of 2025.With more than $289 million in net cash, the company retains considerable flexibility and balance sheet strength for future M&A, organic investment, dividend growth and share repurchases under this renewed repurchase program.The company reported fourth-quarter adjusted earnings of $1.41 per share, which exceeded the Zacks Consensus Estimate of $1.36. This compares to earnings of $1.84 per share a year ago. The company surpassed Zacks Consensus Estimate in three of the trailing four quarters while meeting once, with an average surprise being roughly 3%.IOSP, on its fourth-quarter call, said that it is well placed for continued full-year growth in Performance Chemicals and Fuel Specialties and sequential quarterly recovery in Oilfield Services.Shares of Innospec have lost 19.7% over the past year compared with an 12.3% decline of its industry.Image Source: Zacks Investment ResearchIOSP’s Rank & Key PicksIOSP currently carries a Zacks Rank #4 (Sell).Better-ranked stocks in the basic materials space include Carpenter Technology Corporation CRS, ArcelorMittal MT and Axalta Coating Systems Ltd. AXTACarpenter Technology currently carries a Zacks Rank #2 (Buy). CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.7%. The company's shares have soared 179.7% in the past year. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.The Zacks Consensus Estimate for ArcelorMittal’s current-year earnings is pegged at $3.72 per share. MT, carries a Zacks Rank #2, surpassed the Zacks Consensus Estimate in three of the trailing four quarters but missed it in one, with an average earnings surprise of 4.11%. The company's shares have soared 18.6% in the past year.Axalta Coating Systems, which currently carries a Zacks Rank #1, beat the consensus estimate in each of the trailing four quarters. In this time frame, it has delivered an earnings surprise of roughly 16.3%, on average. AXTA’s shares have rallied 0.7% over the past year.  5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ArcelorMittal (MT): Free Stock Analysis Report Carpenter Technology Corporation (CRS): Free Stock Analysis Report Innospec Inc. (IOSP): Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Innospec

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Innospec

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Innospec IncShs

Wer­bung

Analysen zu Innospec IncShs

DatumRatingAnalyst
09.11.2017Innospec NeutralMonness, Crespi, Hardt & Co.
22.08.2017Innospec BuyMonness, Crespi, Hardt & Co.
19.12.2016Innospec NeutralMonness, Crespi, Hardt & Co.
04.11.2016Innospec BuyMonness, Crespi, Hardt & Co.
12.10.2015Innospec NeutralMonness, Crespi, Hardt & Co.
DatumRatingAnalyst
22.08.2017Innospec BuyMonness, Crespi, Hardt & Co.
04.11.2016Innospec BuyMonness, Crespi, Hardt & Co.
DatumRatingAnalyst
09.11.2017Innospec NeutralMonness, Crespi, Hardt & Co.
19.12.2016Innospec NeutralMonness, Crespi, Hardt & Co.
12.10.2015Innospec NeutralMonness, Crespi, Hardt & Co.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Innospec IncShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen